Effective June 1, 2023, Geraldine Schenk will assume the position of Managing Director of Janssen Poland.Geraldine Schenk began her career at Johnson & Johnson in 2003 at Janssen Switzerland, where she was promoted several times, eventually serving as Chief Commercial Officer and Board Member of...
NMOSD (Devic's disease) is a rare disease of the central nervous system, characterized by severe bouts of optic neuritis and spinal myelitis, which, if untreated, leads to severe patient disability. As of November 1, 2022, NMOSD patients have gained access to a modern treatment that beneficially...
In the OJ The Ministry of Health published the Announcement of the Minister of Health of January 13, 2023 on the list of medicinal products, foodstuffs for particular nutritional uses and medical devices at risk of lack of availability on the territory of the Republic of Poland.
On Friday, the Sejm will most likely pass the act on clinical trials together with the introduced amendment enabling pharmacists to issue prescriptions for influenza vaccines. MPs, both from the opposition and PiS, however, want an "amendment to the amendment" so that pharmacies can issue...
Tens of thousands of antibiotics will hit the market. As the Minister of Health Adam Niedzielski announced on Twitter, this will happen thanks to the release of drugs from the Government Strategic Reserves Agency.
On Monday, January 9, the next meeting of the Transparency Council.
In the OJ The Ministry of Health published the Announcement of the Minister of Health of December 28, 2022 on the list of medicinal products, foodstuffs for particular nutritional uses and medical devices at risk of lack of availability on the territory of the Republic of Poland.
Krzysztof Kopeć, President of the National Drug Manufacturers: The most important events of 2022 - Russia's attack on Ukraine and the economic crisis - also affected our industry. The refugee crisis has caused an increase in the demand for medicines in Poland, and together with the Ministry of...
From November 1, 2022, a new drug program B.138.FM is in force, addressed to the treatment of people with the spectrum of optic neuritis and spinal cord inflammation (NMOSD). As part of it, patients are to receive a modern drug from the class of monoclonal antibodies - satralizumab. However,...
The Ministry of Health has published a draft announcement of the Minister of Health on the list of reimbursed drugs, foodstuffs for particular nutritional uses and medical devices, which will enter into force on January 1, 2023. Possible comments on the draft Announcement of the Minister of...
On Monday, December 19, the next meeting of the Transparency Council.
“There is no risk of a systemic lack of medicines in Poland,” reassures Deputy Minister of Health Maciej Miłkowski in response to the intervention of the Ombudsman Marcin Wiącek in connection with reports of difficulties in accessing morphine medicines.
On November 3, 2022, the 10th meeting of the Medical Fund Council was held, attended by its members and invited guests.
Another report of the European Commission "Vaccine Confidence Project" has been published, which shows that after two years of the pandemic, confidence in vaccination across the EU has decreased. This also applies to Poland.
On November 18, the Regulation of the Minister of Health of October 27, 2022 on the basic conditions for running a pharmacy was published in the Journal of Laws of the Republic of Poland.
Pancreatic cancer is one of the deadliest cancers. The World Pancreatic Cancer Day, celebrated in November, is a special occasion to draw attention to the need to seek innovative methods of treating this disease.
On Monday, November 21, the next meeting of the Transparency Council.
On Monday, October 31, another meeting of the Transparency Council.
The Parliamentary Health Committee recommends that the Sejm adopt the presidential draft amendment to the Medical Fund Act. Also, opposition deputies, despite reservations and proposed amendments, claimed that the changes were necessary and were going in the right direction.
On Monday, October 24, there will be a meeting of the Transparency Council. AOTMiT publishes the update.
The Supreme Administrative Court stated that transferring the authorization to run a generally accessible pharmacy to a franchisee who is controlled, and therefore dependent on the franchisor, would violate the anti-concentration provisions introduced by the "Pharmacy for a Pharmacist" act,...
Problems with the availability of certain drugs, including some antibiotics, result from, among others, from poor prediction of the demand for them by manufacturers, as well as the tendency to use drugs in off-label indications. On Tuesday, the Ministry of Health took a position on the shortages...
In Journal of Laws The Ministry of Health published an Notice of the Minister of Health of October 18, 2022 on the list of medicinal products, foodstuffs for particular nutritional uses and medical devices at risk of unavailability in the territory of the Republic of Poland.
On Monday, October 24, there will be a meeting of the Transparency Council.
- Dermatologists, rheumatologists, but most of all patients suffering from psoriatic arthritis, are waiting for interleukin 23 inhibitors to be reimbursed also in our country - said Prof. dr hab. n. med. Joanna Narbutt, National Consultant for Dermatology and Venereology.
Can modern pharmacology deal effectively with pain? What are the risks of choosing the wrong pain treatment? Prof. Jarosław Woroń, head of the Department of Clinical Pharmacology at the Department of Pharmacology, Faculty of Medicine, CMUJ.
The next meeting of the Transparency Council will be held on Monday, October 3.
During the General Meeting of Members of the "FARMACJA POLSKA" Chamber of Commerce, the management board was appointed for a new, three-year term. Irena Rej was re-elected as the president, who has held this position continuously for 30 years. Krzysztof Adamcewicz (Roche) became the vice...
About the startup market in Poland, medical data and artificial intelligence, the president of the Medical Research Agency, Dr. n. med. Radosław Sierpiński.
On September 9, 2022, during the international conference of the European Society of Medical Oncology (ESMO), updates of two phase III clinical trials (PAOLA and SOLO-1) of olaparib conducted in patients with advanced ovarian cancer (FIGO III + FIGO IV) in first-line maintenance treatment were...
© 2023 Medexpress. All Rights Reserved
